Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
Crossref DOI link: https://doi.org/10.1007/s00417-016-3477-9
Published Online: 2016-08-30
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Meidong
Wijeyakumar, Wijeyanthy
Syed, Adil R.
Joachim, Nichole
Hong, Thomas
Broadhead, Geoffrey K.
Li, Haitao
Luo, Kehui
Chang, Andrew
Funding for this research was provided by:
Financial support was provided in part by Bayer Corporation
License valid from 2016-08-30